Bristol Myers Squibb (NYSE:BMY) said on Tuesday that it has entered into a partnership with Microsoft (NASDAQ:MSFT) to ...
Bristol Myers Squibb said on Tuesday it had signed an agreement with Microsoft to use the tech company's AI-enabled radiology ...
Microsoft and Bristol Myers Squibb join forces to advance AI lung cancer detection, aiming to improve early diagnosis and ...
Ibuprofen may be doing more than easing aches and pains—it could also help reduce the risk of some cancers. Studies have ...
A research team has made a breakthrough in epigenetic drug discovery. The researchers have successfully developed a ...
Ibuprofen is a household name – the go-to remedy for everything from headaches to period pain. But recent research suggests ...
A new gene therapy for people who can have a stem cell transplant but do not have a suitable donor has been approved.
The SFDA is the first regulatory authority globally to grant conditional approval for this medication for the treatment of NSCLC ...
Despite a significant 48.8% objective response rate and breakthrough therapy status, this regulatory shift reverses years of ...
By Elizabeth Chapin University of Kentucky The University of Kentucky Markey Cancer Center has treated the first patient in ...
Health and Me on MSN
Anktiva approved in Saudi Arabia as world’s first lung cancer therapy — all you need to know
Saudi Arabia approves Anktiva, an IL-15 immunotherapy, for bladder and lung cancer, marking its first regulatory clearance ...
The drug is not considered a cure, but results emerging from clinical trials point to the first major advancement in decades ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback